An investigation into the role of Bcl-2 in neuroendocrine differentiation

Biochemical and Biophysical Research Communications

Volumn 326, Issue 2, 2005, Pages 442-448

  Cadden, I S ^a   Johnston, B T ^a   Connolly, R ^a   Gates, D ^a   Tsujimoto, Y ^b   Eguchi, Y ^b   McGinty, A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Biopeptide; Chromogranin A; Differentiation; Immunocytochemistry; PC12; Phaeochromocytoma

Indexed keywords

CHROMOGRANIN A; ENOLASE; GENE PRODUCT; PANCREAS POLYPEPTIDE; POLYPEPTIDE; PROTEIN BCL 2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; FLUORESCENCE; GENETIC ENGINEERING; IMMUNOCYTOCHEMISTRY; NEUROSECRETORY CELL; NONHUMAN; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CHROMOGRANIN A; CHROMOGRANINS; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; ISOENZYMES; NEUROSECRETORY SYSTEMS; PC12 CELLS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; UP-REGULATION;

EID: 9944259462     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.11.046     Document Type: Article

References (20)

1. S. Willis, C.L. Day, M.G. Hinds, and D.C. Huang The Bcl-2-regulated apoptotic pathway J. Cell Sci. 116 2003 4053 4056
2. J.L. Townson, G.N. Naumov, and A.F. Chambers The role of apoptosis in tumor progression and metastasis Curr. Mol. Med. 3 2003 631 642
3. R.H. Pierce, M.E. Vail, L. Ralph, J.S. Campbell, and N. Fausto Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci Am. J. Pathol. 160 2002 1555 1560
4. N. Shivapurkar, J. Reddy, P.M. Chaudhary, and A.F. Gazdar Apoptosis and lung cancer: a review J. Cell. Biochem. 88 2003 885 898
5. D.E. Merry, D.J. Veis, W.F. Hickey, and S.J. Korsmeyer Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS Development 120 1994 301 311
6. S.X. Jiang, T. Kameya, Y. Sato, N. Yanase, H. Yoshimura, and T. Kodama Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation Am. J. Pathol. 148 1996 837 846
7. T. Ohmori, S. Asahi, C. Sato, F. Maki, A. Masumoto, and K. Okada Bcl-2 protein expression and gut neurohormonal polypeptide/amine production in colorectal carcinomas and tumor-neighbouring mucosa, which closely correlate to the occurrence of tumour Histol. Histopathol. 14 1999 37 44
8. C. Azzoni, C. Doglioni, G. Viale, G. Delle Fave, M. De Boni, P. Caruana, G. Ferraro, and C. Bordi Involvement of Bcl-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids Am. J. Surg. Pathol. 20 1996 433 441
9. S. Tagami, Y. Eguchi, M. Kinoshita, M. Takeda, and Y. Tsujimoto A novel protein, RTN-xs, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity Oncogene 19 2000 5736 5746
10. S. Shimizu, Y. Eguchi, W. Kmiike, S. Waguri, Y. Uchiyama, H. Matsuda, and Y. Tsujimoto Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions Oncogene 12 1996 2045 2050
11. A. McGinty, Y.W.E. Chang, A. Sorokin, D. Bokemeyer, and M.J. Dunn Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor differentiated PC12 cells J. Biol. Chem. 275 2000 12095 12101
12. C.M Gleeson, W.J. Curry, C.F. Johnston, and K.D. Buchanan Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia J. Endocrinol. 151 1996 409 420
13. R.T. Cunningham, C.F. Johnston, G.B. Irvine, E.M. McIrath, A. McNeill, and K.D. Buchanan Development of a radioimmunoassay for neurone specific enolase (NSE) and its application in the study of patients receiving intrahepatic arterial streptozotocin and floxuridine Clin. Chim. Acta 189 1990 275 286
14. R.T. Cunningham, K.M. Pogue, W.J. Curry, C.F. Johnston, J.M. Sloan, and K.D. Buchanan Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids J. Pathol. 187 1999 321 325
15. S.P. Mah, L.T. Zhong, Y. Liu, A. Roghani, R.H. Edwards, and D.E. Bresden The protooncogene bcl-2 inhibits apoptosis in PC12 cells J. Neurochem. 60 1993 1183 1186
16. L. Lindenboim, R. Haviv, and R. Stein Inhibition of drug-induced apoptosis by survival factors in PC12 cells J. Neurochem. 64 1995 1054 1063
17. R.T. Cunningham, K.M. Pogue, W.J. Curry, C.F. Johnston, and K.D. Buchanan PC12 cells show immunoreactivity to a number of proteins and peptides, including vasostatin Peptides 17 1996 1297 1301
18. R.R. De Krijger, E. Van Der Hurst, F. Van Der Ham, T. Stijnen, W.N.M. Dinjens, J.W. Koper, H.A. Bruining, S.W.J. Lamberts, and F.T. Bosman Prognostic value of p53, Bcl-2 and c-erbB-2 protein expression in phaeochromocytomas J. Pathol. 188 1999 51 55
19. A.A. Gal, M.N. Sheppard, J.D. Nolan, and C. Cohen p53, cellular proliferation and apoptosis-related factors in thymic neuroendocrine tumours Mod. Pathol. 17 2004 33 39
20. D.G. Wang, C.F. Johnston, and K.D. Buchanan Oncogene expression in gastroenteropancreatic neuroendocrine tumours. Implications for pathogenesis Cancer 80 1997 668 675